Abstract: The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding proteins associated with Parkinson's disease. In particular, the animals or cells are generated using a zinc finger nuclease-mediated editing process. Also provided are methods of using the genetically modified animals or cells disclosed herein to study PD development and screen agents for assessing their effect on progression or symptoms of PD.
Type:
Application
Filed:
July 23, 2010
Publication date:
January 27, 2011
Applicant:
SIGMA-ALDRICH CO.
Inventors:
Edward Weinstein, Xiaoxia Cui, Phil Simmons
Abstract: The present invention provides a genetically modified equine or cell comprising at least one edited chromosomal sequence. In particular, the chromosomal sequence is edited using a zinc finger nuclease-mediated editing process. The disclosure also provides zinc finger nucleases that target specific chromosomal sequences in the equine genome.
Type:
Application
Filed:
July 23, 2010
Publication date:
January 27, 2011
Applicant:
Sigma-Aldrich Co.
Inventors:
Joseph Bedell, Brian Buntaine, Xiaoxia Cui
Abstract: The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding proteins that are associated with cognitive disorders. In particular, the animals or cells are generated using a zinc finger nuclease-mediated editing process. Also provided are methods of using the genetically modified animals or cells disclosed herein to screen agents for toxicity and other effects.
Type:
Application
Filed:
July 23, 2010
Publication date:
January 27, 2011
Applicant:
SIGMA-ALDRICH CO.
Inventors:
Edward Weinstein, Phil Simmons, Xiaoxia Cui
Abstract: The present invention provides a genetically modified rabbit or cell comprising at least one edited chromosomal sequence. In particular, the chromosomal sequence is edited using a zinc finger nuclease-mediated editing process. The disclosure also provides zinc finger nucleases that target specific chromosomal sequences in the rabbit genome.
Type:
Application
Filed:
July 23, 2010
Publication date:
January 27, 2011
Applicant:
SIGMA-ALDRICH CO.
Inventors:
Joseph Bedell, Brian Buntaine, Xiaoxia Cui
Abstract: The present invention provides genetically modified animals and cells comprising edited chromosomal sequences involved in tumor suppression. In particular, the animals or cells are generated using a zinc finger nuclease-mediated editing process. The invention also provides zinc finger nucleases that target chromosomal sequence involved in tumor suppression and the nucleic acids encoding the zinc finger nucleases. Also provided are methods of assessing the effects of agents in genetically modified animals and cells comprising edited chromosomal sequences involved in tumor suppression.
Type:
Application
Filed:
July 23, 2010
Publication date:
January 27, 2011
Applicant:
SIGMA-ALDRICH CO.
Inventors:
Edward Weinstein, Xiaoxia Cui, Phil Simmons
Abstract: The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding proteins that are associated with cognitive disorders. In particular, the animals or cells are generated using a zinc finger nuclease-mediated editing process. Also provided are methods of assessing the effects of agents in genetically modified animals and cells comprising edited chromosomal sequences associated with cognitive disorders.
Type:
Application
Filed:
July 23, 2010
Publication date:
January 27, 2011
Applicant:
SIGMA-ALDRICH CO.
Inventors:
Edward Weinstein, Xiaoxia Cui, Phil Simmons
Abstract: The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding proteins associated with ASD. In particular, the animals or cells are generated using a zinc finger nuclease-mediated editing process. Also provided are methods of using the genetically modified animals or cells disclosed herein to study ASD development and screen agents for assessing their effect on progression or symptoms of an ASD.
Type:
Application
Filed:
July 23, 2010
Publication date:
January 27, 2011
Applicant:
SIGMA-ALDRICH CO.
Inventors:
Edward Weinstein, Xiaoxia Cui, Phil Simmons
Abstract: The present invention provides a genetically modified feline or cell comprising at least one edited chromosomal sequence. In particular, the chromosomal sequence is edited using a zinc finger nuclease-mediated editing process. The disclosure also provides zinc finger nucleases that target specific chromosomal sequences in the feline genome.
Type:
Application
Filed:
July 23, 2010
Publication date:
January 27, 2011
Applicant:
SIGMA-ALDRICH CO.
Inventors:
Joseph Bedell, Gregory Davis, Shondra Miller, Brian Buntaine, Xiaoxia Cui
Abstract: The present invention provides a genetically modified silkworm or cell comprising at least one edited chromosomal sequence. In particular, the chromosomal sequence is edited using a zinc finger nuclease-mediated editing process. The disclosure also provides zinc finger nucleases that target specific chromosomal sequences in the silkworm genome.
Type:
Application
Filed:
July 23, 2010
Publication date:
January 27, 2011
Applicant:
SIGMA-ALDRICH CO.
Inventors:
Joseph Bedell, Brian Buntaine, Xiaoxia Cui
Abstract: The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding proteins associated with AD. In particular, the animals or cells are generated using a zinc finger nuclease-mediated editing process. Also provided are methods of using the genetically modified animals or cells disclosed herein to study AD development and methods of assessing the effects of agents in genetically modified animals and cells comprising edited chromosomal sequences encoding proteins associated with AD.
Type:
Application
Filed:
July 23, 2010
Publication date:
January 27, 2011
Applicant:
SIGMA-ALDRICH CO.
Inventors:
Edward Weinstein, Xiaoxia Cui, Phil Simmons
Abstract: The present invention provides a genetically modified ovine or cell comprising at least one edited chromosomal sequence. In particular, the chromosomal sequence is edited using a zinc finger nuclease-mediated editing process. The disclosure also provides zinc finger nucleases that target specific chromosomal sequences in the ovine genome.
Type:
Application
Filed:
July 23, 2010
Publication date:
January 27, 2011
Applicant:
SIGMA-ALDRICH CO.
Inventors:
Joseph Bedell, Brian Buntaine, Xiaoxia Cui
Abstract: The present invention provides genetically modified animals and cells comprising edited chromosomal involved in cardiovascular disease. In particular, the animals or cells are generated using a zinc finger nuclease-mediated editing process. The invention also provides zinc finger nucleases that target chromosomal sequences involved in cardiovascular disease and the nucleic acids encoding said zinc finger nucleases. Also provided are methods of using the genetically modified animals or cells disclosed herein to screen agents for toxicity and other effects.
Type:
Application
Filed:
July 23, 2010
Publication date:
January 27, 2011
Applicant:
SIGMA-ALDRICH CO.
Inventors:
Edward Weinstein, Xiaoxia Cui, Phil Simmons
Abstract: The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding proteins associated with addiction disorders. In particular, the animals or cells are generated using a zinc finger nuclease-mediated editing process. The invention also provides zinc finger nucleases that target chromosomal sequence encoding addiction-related proteins and the nucleic acids encoding said zinc finger nucleases. Also provided are methods of using the genetically modified animals or cells disclosed herein to screen agents for addiction and withdrawal side effects and other effects.
Type:
Application
Filed:
July 23, 2010
Publication date:
January 27, 2011
Applicant:
SIGMA-ALDRICH CO.
Inventors:
Edward Weinstein, Xiaoxia Cui, Phil Simmons
Abstract: The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding proteins that are associated with neurodevelopmental disorders. In particular, the animals or cells are generated using a zinc finger nuclease-mediated editing process. Also provided are methods of using the genetically modified animals or cells disclosed herein to screen agents for toxicity and other effects.
Type:
Application
Filed:
July 23, 2010
Publication date:
January 27, 2011
Applicant:
SIGMA-ALDRICH CO.
Inventors:
Edward Weinstein, Xiaoxia Cui, Phil Simmons
Abstract: The present invention provides genetically modified animals and cells comprising edited chromosomal sequences associated with schizophrenia. In particular, the animals or cells are generated using a zinc finger nuclease-mediated editing process. The invention also provides zinc finger nucleases that target chromosomal sequence associated with schizophrenia and the nucleic acids encoding said zinc finger nucleases. Also provided are methods of assessing the effects of agents in genetically modified animals and cells comprising edited chromosomal sequences associated with schizophrenia.
Type:
Application
Filed:
July 23, 2010
Publication date:
January 27, 2011
Applicant:
SIGMA-ALDRICH CO.
Inventors:
Edward Weinstein, Xiaoxia Cui, Phil Simmons
Abstract: This invention relates to an amorphous non-glassy ceramic composition that may be prepared by curing, calcining and/or pyrolyzing a precursor material comprising silicon, a Group III metal, a Group IVA metal, and/or a Group IVB metal.
Abstract: The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding inflammation-related proteins. In particular, the animals or cells are generated using a zinc finger nuclease-mediated editing process. Also provided are methods of assessing the effects of agents in genetically modified animals and cells comprising edited chromosomal sequences encoding inflammation-related proteins.
Type:
Application
Filed:
July 23, 2010
Publication date:
January 20, 2011
Applicant:
SIGMA-ALDRICH CO.
Inventors:
Edward Weinstein, Xiaoxia Cui, Phil Simmons
Abstract: The present invention provides a genetically modified canine or cell comprising at least one edited chromosomal sequence. In particular, the chromosomal sequence is edited using a zinc finger nuclease-mediated editing process. The disclosure also provides zinc finger nucleases that target specific chromosomal sequences in the canine genome.
Type:
Application
Filed:
July 23, 2010
Publication date:
January 20, 2011
Applicant:
SIGMA-ALDRICH CO.
Inventors:
Joseph Bedell, Brian Buntaine, Xiaoxia Cui
Abstract: The present invention provides genetically modified animals and cells comprising edited chromosomal sequences encoding proteins that are associated with neurotransmission disorders. In particular, the animals or cells are generated using a zinc finger nuclease-mediated editing process. Also provided are methods of using the genetically modified animals or cells disclosed herein to screen agents for toxicity and other effects.
Type:
Application
Filed:
July 23, 2010
Publication date:
January 20, 2011
Applicant:
SIGMA-ALDRICH CO.
Inventors:
Edward Weinstein, Xiaoxia Cui, Phil Simmons